Tremor and Other Hyperkinetic Movements

Scope & Guideline

Pioneering research for transformative clinical practices.

Introduction

Welcome to the Tremor and Other Hyperkinetic Movements information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Tremor and Other Hyperkinetic Movements, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2160-8288
PublisherUBIQUITY PRESS LTD
Support Open AccessYes
Country-
TypeJournal
Convergefrom 2012 to 2024
AbbreviationTREMOR OTHER HYPERK / Tremor Other Hyperkinetic Mov.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUnit 3N, 6 Osborn Street, LONDON E1 6TD, ENGLAND

Aims and Scopes

The journal 'Tremor and Other Hyperkinetic Movements' focuses on advancing the understanding, diagnosis, and treatment of tremors and related hyperkinetic movement disorders. It serves as a platform for sharing innovative research findings, clinical experiences, and therapeutic advancements in this specialized field.
  1. Study of Tremor Phenomenology:
    The journal emphasizes detailed investigations into different types of tremors, including essential tremor, dystonic tremor, and other movement disorders, aiming to enhance clinical understanding and management.
  2. Clinical and Genetic Research:
    There is a strong focus on the intersection of clinical presentations and genetic factors, exploring how genetic variants contribute to hyperkinetic movement disorders and their phenotypic expression.
  3. Innovative Therapeutic Approaches:
    The journal covers various therapeutic interventions, including pharmacological treatments, deep brain stimulation, and novel therapies like transcutaneous afferent patterned stimulation, highlighting their effectiveness in managing movement disorders.
  4. Patient-Centric Outcomes:
    Research often focuses on patient-reported outcomes and quality of life measures, assessing how different treatments impact daily living and overall well-being in patients with movement disorders.
  5. Multidisciplinary Collaboration:
    The journal promotes collaboration between neurologists, geneticists, physiotherapists, and other healthcare professionals to address the complexities of hyperkinetic movement disorders.
The journal has actively responded to emerging trends and themes in the field of hyperkinetic movement disorders. This section outlines the recent themes that have gained traction, reflecting the evolving landscape of research and clinical practice.
  1. Integration of Genetic Testing:
    There is a growing trend towards integrating genetic testing and analysis into the clinical management of movement disorders, facilitating personalized treatment plans based on genetic profiles.
  2. Use of Digital Health Technologies:
    Recent publications highlight the use of digital health technologies, such as smartphone applications for tracking symptoms and facilitating telemedicine consultations, as innovative approaches to managing tremors.
  3. Focus on Functional Movement Disorders:
    There is an increasing emphasis on understanding and treating functional movement disorders, reflecting a shift in clinical interest and the need for multidisciplinary approaches in management.
  4. Longitudinal Studies on Treatment Outcomes:
    Emerging trends include longitudinal studies examining the long-term effects of various treatments on tremor and hyperkinetic disorders, providing valuable insights into the sustainability of therapeutic benefits.
  5. Exploration of Neuroinflammatory Mechanisms:
    Research into the neuroinflammatory mechanisms underlying movement disorders is gaining traction, suggesting a potential area for therapeutic intervention and novel treatment strategies.

Declining or Waning

While the journal continues to evolve, certain themes have seen a decline in prominence. This section highlights topics that have become less frequent in recent publications, indicating shifts in research focus or changes in clinical relevance.
  1. Historical Perspectives on Treatment:
    There has been a noticeable decrease in papers solely focused on historical treatment approaches for movement disorders, reflecting a shift towards more contemporary and evidence-based practices.
  2. Non-Pharmacological Interventions:
    Research on non-pharmacological interventions, such as behavioral therapies for movement disorders, appears to be waning, possibly due to a growing emphasis on pharmacological and surgical options.
  3. General Epidemiological Studies:
    While epidemiological studies are important, there seems to be a gradual reduction in broad epidemiological analyses, with more emphasis now on specific genetic or clinical characteristics of movement disorders.
  4. Aging and Movement Disorders:
    The exploration of aging-related movement disorders has diminished, which may be attributed to a more focused approach on younger populations or specific genetic conditions.

Similar Journals

ERJ Open Research

Elevating the Standards of Open Access Research
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: Frequency: 4 issues/year

ERJ Open Research is a distinguished Open Access journal dedicated to advancing the field of pulmonary and respiratory medicine, published by the European Respiratory Society Journals Ltd. Established in 2015, the journal proudly provides a platform for innovative research and comprehensive studies that address vital questions in respiratory health. With an impressive Q1 ranking in Scopus for Pulmonary and Respiratory Medicine and positioned in the top 73rd percentile among its peers, ERJ Open Research is a critical resource for researchers, clinicians, and students alike. The journal’s commitment to open access ensures that high-quality research is readily available to the global community, fostering collaboration and knowledge-sharing. Whether you are looking to publish groundbreaking findings or stay updated on the latest advancements in respiratory medicine, ERJ Open Research is the premier destination for impactful scholarly contributions.

npj Parkinsons Disease

Fostering collaboration for a deeper understanding of Parkinson's.
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

npj Parkinsons Disease is a leading open-access journal dedicated to advancing research in the field of Parkinson's disease and related neurodegenerative disorders. Published by NATURE PORTFOLIO, this journal has been on the forefront of scientific inquiry since its inception in 2015, providing a high-quality platform for the dissemination of groundbreaking research. The journal's reputation is underscored by its impressive Q1 rankings in Cellular and Molecular Neuroscience and Neurology categories, as well as its commendable positions in Scopus rankings, placing it within the top echelons of neuroscience and clinical neurology research. With its focus on innovative methodologies and translational studies, npj Parkinsons Disease aims to foster collaboration among researchers, clinicians, and healthcare professionals, ultimately contributing to the improved understanding and treatment of Parkinson's disease. Researchers, professionals, and students are encouraged to explore its rich repository of knowledge, accessible freely since its launch, to stay abreast of the latest developments in this critical area of neuroscience.

NEUROMUSCULAR DISORDERS

Unraveling complexities of neuromuscular diseases.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0960-8966Frequency: 12 issues/year

NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.

Intractable & Rare Diseases Research

Exploring the Frontiers of Intractable Illnesses.
Publisher: INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENTISSN: 2186-3644Frequency: 4 issues/year

Intractable & Rare Diseases Research is a pioneering journal dedicated to advancing the understanding and treatment of rare and intractable diseases. Published by INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT in Japan, this esteemed journal serves as a critical platform for researchers, clinicians, and healthcare professionals to share groundbreaking findings and developments in the field. With its established Scopus ranking of #238 out of 636 in the General Medicine category, placing it in the 62nd percentile, and its classification in the Q3 quartile for 2023, it is recognized as a significant contributor to the literature on rare diseases. Operating without an open-access model, the journal ensures high-quality content cultivated through rigorous peer-review processes. Through its scope spanning from 2012 to 2024, the journal aspires to bridge gaps in knowledge and foster collaboration among interdisciplinary researchers, ultimately aiming to improve patient outcomes and enhance public health concerning these challenging conditions.

RESTORATIVE NEUROLOGY AND NEUROSCIENCE

Advancing Neural Restoration: Pioneering Research in Neurology and Neuroscience
Publisher: IOS PRESSISSN: 0922-6028Frequency: 6 issues/year

RESTORATIVE NEUROLOGY AND NEUROSCIENCE, published by IOS PRESS, is a premier journal dedicated to advancing the fields of neurology and neuroscience. Since its inception in 1989, this journal has played a crucial role in disseminating cutting-edge research findings and innovative therapeutic approaches that aim to restore neurological function and improve patient outcomes. With a focus on developmental neuroscience and clinical neurology, the journal holds a 2023 Scopus ranking of #129 out of 400 in clinical neurology, and #15 out of 37 in developmental neuroscience, reflecting its significant influence in these domains. Although it operates on a non-open access model, RESTORATIVE NEUROLOGY AND NEUROSCIENCE offers valuable insights for researchers, healthcare professionals, and students seeking to deepen their understanding of neural restoration mechanisms and therapeutic strategies. Located in Amsterdam, Netherlands, the journal continues to foster scholarly dialogue and innovation, contributing to the global advancement of neuroscience and neurology.

Epilepsi

Fostering breakthroughs in epilepsy management and care.
Publisher: KARE PUBLISSN: 1300-7157Frequency: 3 issues/year

Epilepsi is an esteemed academic journal dedicated to advancing the field of epilepsy research and treatment, published by KARE PUBL. With its open access model established since 2017, the journal ensures that vital research findings are easily accessible to a global audience, thereby fostering collaboration and knowledge sharing among researchers, healthcare professionals, and students. The journal focuses on a comprehensive range of topics within neurology, including clinical studies, therapeutic advancements, and innovative approaches to epilepsy management. Located in Istanbul, Turkey, Epilepsi aims to bridge the gap between research and practice, enhancing understanding and patient care for individuals affected by epilepsy. Its commitment to high-quality, peer-reviewed content makes it a significant resource for anyone involved in epilepsy research or clinical practice.

Brain Stimulation

Unveiling the mechanisms of neural enhancement.
Publisher: ELSEVIER SCIENCE INCISSN: 1935-861XFrequency: 6 issues/year

Brain Stimulation, published by Elsevier Science Inc, stands at the forefront of the interdisciplinary fields of biophysics, neurology, and neuroscience. With an impressive Q1 ranking in its categories and notable Scopus rankings—evidencing its influence in the realm of clinical neurology and general neuroscience—it serves as a critical platform for researchers seeking to disseminate innovative findings related to the applications and mechanisms of brain stimulation techniques. As an esteemed journal with a history of publication since 2008, Brain Stimulation is dedicated to enhancing our understanding of brain function through rigorous scientific inquiry and provides insights that are invaluable for both practitioners and academics alike. This journal exemplifies the importance of advancing research in therapeutic brain interventions, making it a vital resource for anyone involved in the neurological sciences.

Neurology and Clinical Neuroscience

Exploring innovative solutions in neurological health.
Publisher: WILEYISSN: 2049-4173Frequency: 6 issues/year

Neurology and Clinical Neuroscience, published by WILEY, is a pivotal peer-reviewed journal dedicated to advancing knowledge in the fields of neurology and clinical neuroscience. With an ISSN of 2049-4173, it encompasses a diverse range of topics related to neurological disorders, offering a platform for groundbreaking research and clinical practices. Although the journal does not currently operate under an open access model, it aims to foster an inclusive academic environment by providing high-quality content that is accessible to both specialists and general practitioners in the medical community. Despite its relatively recent establishment from 2013 to 2024, the journal has gained recognition with Scopus rankings highlighting its role in clinical neurology and neuroscience spheres. It serves as an essential resource for researchers, professionals, and students seeking to expand their understanding and engage in current discussions surrounding neurological health and diseases.

DERMATOLOGY

Empowering professionals with cutting-edge insights.
Publisher: KARGERISSN: 1018-8665Frequency: 6 issues/year

DERMATOLOGY, an esteemed journal published by KARGER, is a vital resource in the field of dermatological research and clinical practice. Established in 1893, with its comprehensive coverage extending to 2024, this journal has earned its place as a leading publication, holding a prestigious Q1 quartile ranking in Dermatology and ranking 15th out of 142 in the Scopus Medicine - Dermatology category, reflecting its 89th percentile standing within the discipline. The journal aims to disseminate innovative research findings, critical reviews, and clinical studies that advance the understanding of skin disorders and their treatments. While primarily available through institutional subscriptions, DERMATOLOGY remains committed to enhancing accessibility and fostering international collaboration among researchers, professionals, and students in the dermatological community. Its rigorous peer-review process guarantees the highest quality of published works, making it an essential reference for those dedicated to advancing dermatological science and improving patient care.

Therapeutic Advances in Neurological Disorders

Advancing knowledge for a brighter neurological future.
Publisher: SAGE PUBLICATIONS LTDISSN: 1756-2856Frequency: 1 issue/year

Therapeutic Advances in Neurological Disorders, published by SAGE Publications Ltd, is a leading open access journal dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2008, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for the dissemination of high-quality research that improves the understanding and treatment of neurological disorders. With a commendable impact factor and ranked Q1 in multiple categories, including Neurology and Pharmacology for 2023, it exemplifies excellence in scholarly contributions. The journal's Scope encompasses a wide array of topics, providing insights that are pivotal for clinical practice and pharmacological development. Additionally, with its commitment to open access since 2017, Therapeutic Advances in Neurological Disorders ensures that its research reaches a global audience, fostering collaboration and innovation in neurological science.